Introduction
This is not the first time that illicit fentanyl has been combined with other drugs in the USA which resulted in numerous fatalities. In Wayne County Michigan in 2005 and 2006, the Medical Examiner's Office documented 101 fentanyl-and heroin-related fatalities with half of those cases having detectible cocaine concentrations (1) . During this same time frame, Massachusetts saw 107 fentanyl deaths combined with opiates, cocaine or both (2) . From 2005 to 2007, Cook County Illinois experienced a series of 342 illicit fentanyl deaths with the greatest number of deaths peaking at 47 per month (3, 4) . The fentanyl in the Cook County cases was traced back to a lab in Mexico and once that lab was shut down in 2007 the deaths ceased. In Philadelphia in 2006, the Medical Examiner's Office had a series of seven cases which contained a combination of fentanyl, heroin and the animal tranquilizer xylazine (5) .
Outside of the USA, Sweden had eight fatalities when fentanyl was mixed with a low concentration of amphetamine powders with caffeine, phenazone and sugar as cutting agents (6) .
It is not clear what the motivation is to create such combinations with fentanyl but the resulting mixtures are extremely dangerous with high mortality rates. Fentanyl is an extremely potent synthetic opioid, significantly more potent than morphine.
Experimental
The Montgomery County Coroner's Office (MCCO)/Miami Valley Regional Crime Lab (MVRCL) Toxicology Section performs analyses in both human performance and postmortem forensic toxicology. Cases are received from portions of the southern half of the state of Ohio, which includes urban, suburban and rural areas. The majority of the presented cases originated from urban and suburban areas. The toxicology analyses of each case included: volatile analysis to include methanol, ethanol, isopropanol and acetone; an enzyme-linked immunosorbent assay (ELISA) screen comprised of amphetamine, methamphetamine, barbiturates, benzodiazepines, cannabinoids, carisoprodol, cocaine metabolites and opiates and a basic drug screen by gas chromatography -mass spectrometry (GC -MS) on blood, urine or liver. Cases that presented with a history indicative of illicit drug use were also screened for fentanyl by ELISA. Low concentrations of fentanyl (1 -2 ng/mL) were not always detected in the GC -MS drug screen due to the limit of detection of this method for fentanyl and norfentanyl.
Fentanyl and norfentanyl were confirmed and quantitated by a solid-phase extraction (SPE) method with the eluent derivatized with acetic anhydride and pyridine. The analysis was by GC-MS with a limit of quantitation of 1 ng/mL. Opiates were confirmed and quantitated using an oxime derivatization, SPE and GC -MS with a limit of quantitation of 20 ng/mL. Cocaine and metabolites were confirmed using SPE with BSTFA derivatization and GC-MS with a limit of quantitation of 50 ng/mL. Benzodiazepines were confirmed by liquid chromatography-mass spectrometry and extracted by SPE with a quantitation limit of 10 ng/mL. Gabapentin and lamotrigine were extracted with methanol and confirmed by liquid chromatography -mass spectrometry/mass spectrometry (LC -MS-MS) with a limit of quantitation of 1 mg/mL. Other basic drugs were extracted with SPE and confirmed by gas chromatography -nitrogen -phosphorus detection with a limit of quantitation of 50 ng/mL. Cyclobenzaprine and antidepressants were extracted by SPE and confirmed by LC-MS-MS with a limit of quantitation of 20 ng/mL. Volatiles were analyzed by headspace gas chromatography with both flame ionization and mass spectrometry detection. All SPE columns were supplied by United Chemical Technologies.
The MCCO cases were chosen based on history or toxicology findings of illicit drug use with no evidence or history of prescription use of any pharmaceutical grade fentanyl product. The illicit fentanyl cases comprised: 57 Caucasian males and 24 Caucasian females, 7 African-American males, 1 AfricanAmerican female and 1 bi-racial male, for a total number of 90 cases. The number of decedents and age ranges were Caucasian males 19 -62 years (63.3%), 24 Caucasian females 25 -62 years (26.6%), 7 African-American males aged 20 -66 years (7.7%), 1 African-American female aged 28 (1.1%) and 1 biracial male aged 32 (1.1%). Fourteen different counties in portions of southern Ohio reported cases. Montgomery County had the greatest number of cases at 51 (56.6%). The postmortem data will be divided by cases containing fentanyl without the presence of acute heroin or cocaine, fentanyl and acute heroin, fentanyl and acute cocaine and fentanyl, acute heroin and acute cocaine and finally antemortem cases containing fentanyl and postmortem cases where the cause of death was not due to drugs. Those cases which contained evidence of historic cocaine or heroin use will be described with the fentanyl cases. Historic heroin and cocaine cases are defined as those cases which contained blood morphine of ,20 and no detectable 6-monoacetylmorphine (6-MAM) or cocaine.
Analysis by the MVRCL of seized products consisted of a presumptive color screen for the presence of heroin called the Marquis test. GC -MS was used to confirm the presence of the fentanyl and/or heroin and/or cocaine.
Agilent Technologies was the manufacturer of all of the confirmation and quantitation instrumentation used. To date, the Chemistry Section of the MVRCL received 110 products containing illicit fentanyl in 109 cases with more suspected cases awaiting analysis. Seizures were from seven different counties in portions of southern Ohio. Montgomery County had the greatest number of seizures at 85 or 78%. The products received were 27 as loose powders, 53 as powder in clear gel caps, 17 in syringes, 9 on spoons and 4 as residues. The products consisted of 42 fentanyl only (38%), 57 fentanyl and heroin (52%), 2 fentanyl and cocaine (1.8%) and 9 fentanyl, heroin and cocaine (8%). One submission had one each of fentanyl and fentanyl and heroin.
Results
The toxicology and autopsy results from the 90 cases will be divided by those cases containing fentanyl without acute heroin or cocaine (Table I) , antemortem cases and cases containing fentanyl that were not ruled drug deaths (Table II) , fentanyl and acute heroin (Table III) , fentanyl and acute cocaine (Table IV) and fentanyl, acute heroin and acute cocaine (Table V) . Those cases that contained evidence of historic cocaine or heroin use are listed in Table I .
The cases in Table I are comprised of 40 males ranging in age from 18 to 66 years with an average age of 36 and a median age of 35 and 13 females ranging in age from 25 to 57 years with an average age of 38 and median age of 38. Three of the females did not have age information available. Pulmonary edema was the most common autopsy finding, and there was no relationship between fentanyl concentration and other autopsy findings such as heart disease or chronic obstructive pulmonary disease (COPD).
Cases in Table II include four human performance cases and five postmortem cases. The cases were comprised of five males ranging in age from 20 to 32 years with a median age of 25 and an average age of 24 and four females ranging in age from 24 to 37 years with a median and average age of 29 years. Some of these cases had fentanyl in the presence of acute heroin or cocaine, but the cause of death for the five postmortem cases was something other than a drug overdose. The five cases involving human performance had fentanyl concentrations ranging between 4.4 and 13 ng/mL, with a median of 5.7 and an average of 7.6 for all blood sources. The data from this table clearly demonstrate that toxic and fatal fentanyl concentrations overlap.
Toxicology and autopsy results from 12 cases are displayed in Table III in which fentanyl and acute heroin were the most significant findings. The ages ranged from 30 to 62 years and included three females with an average age of 45 and a median age of 39 years and nine males with an average and median age of 42 years. Morphine concentrations ranged from 20 to 623 ng/mL in blood specimens collected from the periphery with an average of 161 and a median of 105. In the single cavity blood specimen, the morphine concentration was 166 ng/mL. The single blood specimen collected from the heart contained 62 ng/mL of morphine. 6-MAM concentrations ranged from ,5 to 23 ng/mL in blood specimens collected from a peripheral site. In the single cavity blood specimen, the 6-MAM concentration was 44 and 12 ng/ mL of 6-MAM was measured in the single blood specimen collected from the heart. Pulmonary edema was the most common autopsy finding, and there was no relationship between fentanyl concentration and morphine concentration and other autopsy findings such as heart disease or COPD. Case numbers 8 and 9 in Table III are typical for individuals that had likely lost opiate tolerance after being incarcerated.
Toxicology and autopsy results from seven cases are displayed in Table IV in which fentanyl and acute cocaine were the most significant findings. The cases were comprised of two females aged 35 and 42 years and five males aged 30 -51 years with an average age of 37 and a median age of 34. Cocaine concentrations ranged from ,50 to .1,000 ng/mL in blood specimens collected from a peripheral site.
Toxicology and autopsy results from six cases of male decedents are displayed in Table V in which fentanyl, acute heroin and acute cocaine were the most significant findings. The ages ranged from 21 to 59 years with an average age of 42 and a median age of 46. Morphine concentrations ranged from 25 to 387 ng/mL in four blood specimens collected from a peripheral site. Morphine concentrations of 25 and 28 ng/mL were present in two blood specimens collected from the heart. Cocaine concentrations were less 50 -192 ng/mL in four blood specimens collected from a peripheral site. Cocaine concentrations of 50 and 53 ng/mL were present in blood specimens collected from the heart. 6-MAM concentrations ranged from ,5 to 27 ng/mL in blood specimens collected from a peripheral site. Again there was no relationship between drug concentrations and autopsy findings with the most common autopsy finding being pulmonary edema.
Table VI compares the fentanyl concentrations from peripheral blood specimens from Tables I -V. The median fentanyl concentrations from Tables I -IV were not significantly different. Table V did have a significantly different median fentanyl concentration but that could be from the small sample size. Tables I -IV had the same average fentanyl concentrations, but Table V had a significantly higher average fentanyl concentration. Figure 1 shows the expected color of a presumptive color test called the Marquis test that is positive for heroin, a bright purple color. Figure 2 shows the color of the Marquis test when fentanyl is present without heroin, an orange color. At first, some police agencies that were expecting heroin would see this orange test result and conclude that no controlled substances were present and would not submit anything to the lab for testing. This presumptive color test was able to distinguish fentanyl from heroin Ohio Cases Containing Drug Combinations Marketed as Heroin 593 when one product dominated the mixture. However, mixed color results were obtained when the fentanyl and heroin were present as a more equal mixture. If the mixture contained fentanyl and cocaine, the Marquis test would show orange to light orange if the fentanyl was the dominant ingredient. However, if the cocaine was the dominant ingredient, there would be no color reaction in the Marquis test. Figure 3 is a typical seizure of fentanyl powder, Figure 4 is a typical seizure of heroin powder History of heroin and cocaine abuse, syringe with needle on his leg Pulmonary edema c, Caucasian; m, male; f, female; a, African American; br, bi-racial; FB, femoral blood; HB, heart blood; CB, cavity blood; AM, antemortem blood; VIT, vitreous fluid; DPH, diphenhydramine; GABA, gabapentin; EtOH, ethanol; 7AMC, 7-aminoclonazepam; BE, benzoylecgonine; NORSERT, norsertraline; EMS, emergency medical services; IV, intravenous; HTN, hypertension; COPD, chronic obstructive pulmonary disease; ASCVD, atherosclerotic cardiovascular disease obstructive pulmonary disease; 6-MAM, 6-monoacetylmorphine; CO, carbon monoxide; Rx, prescription; UNK, unknown; NORB, norbuprenorphine. Witnessed weaving in and out of lane prior to crashing head on into a something, admitted drug abuse history Antemortem, human performance c, Caucasian; m, male; f, female; a, African American; FB, femoral blood; AM, antemortem blood; HB, heart blood; DPH, diphenhydramine; CO, carbon monoxide; BE, benzoylecgonine; COCA, coca ethylene; EtOH, ethanol; DIAZ, diazepam; NORD, nordiazepam; 6-MAM, 6-monoacetylmorphine; 7AMC, 7-aminoclonazepam; CB, cavity blood.
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and Figure 5 shows five clear gel caps containing heroin powder.
As can be seen in these pictures, the pure fentanyl or heroin is not distinguishable by observation of the powder alone. The same is true for the cocaine and fentanyl mixture. GC -MS was used to confirm the presence of the fentanyl and/or heroin and/or cocaine. The results of these tests showed that fentanyl was present in the mixtures at various concentrations based on the intensity of the peaks produced in the GC -MS data. The concentrations of the fentanyl or other components were not measured; however, representative aliquots of the specimens were analyzed. There was no relationship between the form of the submission and the content of the submission. One submission had one each of fentanyl and fentanyl and heroin. When the powders were received in gel caps, the gel caps were always clear no matter what drugs they contained.
Comparison of the data collected by the MCCO, and the MVRCL shows that both the products seized and the deaths reported were predominately from Montgomery County. However, the majority of the products seized by the MVRCL contained a mixture of fentanyl and heroin but the majority of the death cases reported by the MCCO were from the acute use of products containing illicit fentanyl. The second most seized product from the MVRCL data was the illicit fentanyl, and the second most prevalent product in the MCCO death cases was those containing illicit fentanyl BE, benzoylecgonine; IV, intravenous; HTN, hypertension; rehab, rehabilitation; pos, positive; c, Caucasian; m, male; f, female; FB, femoral blood; CB, cavity blood; HB, heart blood; 7AMC, 7-aminoclonazepam; 6-MAM, 6-monoacetylmorphine; CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease; ASCVD, atherosclerotic cardiovascular disease. and heroin. Apparently, the mixing of the fentanyl with the heroin results in a product that contains less fentanyl and is therefore less potent. The increased death results with use of the fentanyl only products as compared with the fentanyl and heroin products are consistent with the increased potency of the fentanyl over the morphine produced by heroin use.
Discussion and conclusion
Both postmortem and human performance forensic toxicology laboratories should be aware of the increased use of illicit fentanyl in place of and in addition to heroin and cocaine products. Illicit fentanyl and all combinations discussed are still being confirmed in products submitted to the MVRCL, and death cases are still being confirmed from the use of these products by the MCCO. It is evident that heroin users are the most likely victims. Many of the decedents had past heroin use history either by injecting or by snorting the drug. Southern Ohio has a serious heroin problem. MCCO statistics on drug deaths for 2013 showed that 58% of all drug deaths were from heroin. In October 2013, Tables I-V   Table I  Table II  Table III  Table IV  Table V when the illicit fentanyl and combinations began showing up, they outnumbered the heroin only deaths. There is no evidence in these cases that any of the victims intended to die from their drug use. There is no pattern of when or where a certain illicit fentanyl product or combination will show up. When a user consumes their usual amount of drug and it is contaminated with or consisting of all illicit fentanyl, the outcome is most likely dire.
